Search research articles
Contact Us
Filters
Showing results (91-100 of 221) with videos related to
Page
of 23
Sort By:
Cancer
|
October 13, 2007
Medroxyprogesterone, interferon alfa-2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carcinoma of intermediate prognosis: results of a randomized controlled trial
Sylvie Negrier, David Perol, Alain Ravaud, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 18, 2020
Prognostic factors for cancer patient admitted to a medical intensive care unit
Camille Baylot, Adrienne Francopoulo, Marine Gross-Goupil, et al.
BMC Cancer
|
December 5, 2019
Renal cell carcinoma lung metastases treated by radiofrequency ablation integrated with systemic treatments: over 10 years of experience
Alexis Gonnet, Laura Salabert, Guilhem Roubaud, et al.
World Journal of Urology
|
February 16, 2005
Prognostic factors of response or failure of treatment in patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d'Immunothérapie
Sylvie Negrier, Frédéric Gomez, Jean-Yves Douillard, et al.
Bulletin Du Cancer
|
August 12, 2017
[Principles, modalities and indications of the administration of Radium in cancers, focus on metastatic prostate cancer: State of arts]
Pauline Bertolaso, Laura Leroy, Marine Gross-Goupil, et al.
European Urology
|
January 20, 2009
Case study of the month. Complete histologic remission after sunitinib neoadjuvant therapy in T3b renal cell carcinoma
Grégoire Robert, Grégoire Gabbay, Raphaël Bram, et al.
Urologic Oncology
|
November 17, 2009
Targeted therapies in non-muscle-invasive bladder cancer according to the signaling pathways
Hervé Wallerand, Jean-Christophe Bernhard, Stéphane Culine, et al.
Acta Oncologica (Stockholm, Sweden)
|
September 22, 2021
The impact of sarcopenia on the efficacy and safety of immune checkpoint inhibitors in patients with solid tumours
Laura Haik, Aurore Gonthier, Amandine Quivy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 7, 2010
Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (AVOREN): final analysis of overall survival
Bernard Escudier, Joaquim Bellmunt, Sylvie Négrier, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 15, 2005
Phase I study and pharmacokinetic of CHS-828, a guanidino-containing compound, administered orally as a single dose every 3 weeks in solid tumours: an ECSG/EORTC study
Alain Ravaud, Thomas Cerny, Catherine Terret, et al.
Page
of 23
Search research articles
Search
Showing results (91-100 of 221) with videos related to
Sort By:
Page
of 23
Cancer
|
October 13, 2007
Medroxyprogesterone, interferon alfa-2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carcinoma of intermediate prognosis: results of a randomized controlled trial
Sylvie Negrier, David Perol, Alain Ravaud, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 18, 2020
Prognostic factors for cancer patient admitted to a medical intensive care unit
Camille Baylot, Adrienne Francopoulo, Marine Gross-Goupil, et al.
BMC Cancer
|
December 5, 2019
Renal cell carcinoma lung metastases treated by radiofrequency ablation integrated with systemic treatments: over 10 years of experience
Alexis Gonnet, Laura Salabert, Guilhem Roubaud, et al.
World Journal of Urology
|
February 16, 2005
Prognostic factors of response or failure of treatment in patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d'Immunothérapie
Sylvie Negrier, Frédéric Gomez, Jean-Yves Douillard, et al.
Bulletin Du Cancer
|
August 12, 2017
[Principles, modalities and indications of the administration of Radium in cancers, focus on metastatic prostate cancer: State of arts]
Pauline Bertolaso, Laura Leroy, Marine Gross-Goupil, et al.
European Urology
|
January 20, 2009
Case study of the month. Complete histologic remission after sunitinib neoadjuvant therapy in T3b renal cell carcinoma
Grégoire Robert, Grégoire Gabbay, Raphaël Bram, et al.
Urologic Oncology
|
November 17, 2009
Targeted therapies in non-muscle-invasive bladder cancer according to the signaling pathways
Hervé Wallerand, Jean-Christophe Bernhard, Stéphane Culine, et al.
Acta Oncologica (Stockholm, Sweden)
|
September 22, 2021
The impact of sarcopenia on the efficacy and safety of immune checkpoint inhibitors in patients with solid tumours
Laura Haik, Aurore Gonthier, Amandine Quivy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 7, 2010
Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (AVOREN): final analysis of overall survival
Bernard Escudier, Joaquim Bellmunt, Sylvie Négrier, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 15, 2005
Phase I study and pharmacokinetic of CHS-828, a guanidino-containing compound, administered orally as a single dose every 3 weeks in solid tumours: an ECSG/EORTC study
Alain Ravaud, Thomas Cerny, Catherine Terret, et al.
Page
of 23